Literature DB >> 27805273

Comparison between Er:YAG laser and bipolar radiofrequency combined with infrared diode laser for the treatment of acne scars: Differential expression of fibrogenetic biomolecules may be associated with differences in efficacy between ablative and non-ablative laser treatment.

Seonguk Min1,2, Seon Yong Park1,2, Jungyoon Moon1,2, Hyuck Hoon Kwon1,2, Ji Young Yoon2, Dae Hun Suh1,2.   

Abstract

BACKGROUND AND
OBJECTIVE: Fractional Er:YAG minimizes the risk associated with skin ablation. Infrared diode laser and radiofrequency have suggested comparable improvements in acne scar. We compared the clinical efficacy of Er:YAG laser and bipolar radiofrequency combined with diode laser (BRDL) for the treatment of acne scars. Moreover, acute molecular changes of cytokine profile associated with wound healing have been evaluated to suggest mechanisms of improvement of acne scar. STUDY
DESIGN: Twenty-four subjects with mild-to-moderate acne scars were treated in a split-face manner with Er:YAG and BRDL, with two treatment sessions, 4 weeks apart. Objective and subjective assessments were done at baseline, 1, 3, 7 days after each treatment and 4 weeks after last treatment. Skin biopsy specimens were obtained at baseline, 1, 3, 7, 28 days after one session of treatment for investigation of molecular profile of acute skin changes by laser treatment.
RESULTS: Investigator's Global Assessment representing the improvement degree shows 2.1 (50%) in fractional Er:YAG and 1.2 (25%) in BRDL. Er:YAG induced the later and higher peak expression of TGFβs and collagenases, whereas BRDL induced earlier and lower expression of TGFβ and collagenases, relatively. PPARγ dropped rapidly after a peak in Er:YAG-treated side, which is associated with tissue inhibitor of metalloproteinase (TIMP) expression. We observed higher expression of TIMP after Er:YAG treatment compared with BRDL by immunohistochemistry, which may be associated with the expression of upregulation of collagen fibers.
CONCLUSION: The superior efficacy of Er:YAG to BRDL in the treatment of acne scars may be associated with higher expression of collagen which is associated with differential expression of TGFβs, collagenases, PPARγ, and TIMP. Lasers Surg. Med. 49:341-347, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  PPARγ; TGFβ; TIMP; collagen; collagenases

Mesh:

Year:  2016        PMID: 27805273     DOI: 10.1002/lsm.22607

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  7 in total

1.  Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: A prospective study.

Authors:  Ting Lan; Yan Xiao; Li Tang; Michael R Hamblin; Rui Yin
Journal:  Lasers Surg Med       Date:  2018-04-16       Impact factor: 4.025

2.  Prospective trial of a 2940 nm Er:YAG laser for the treatment of meibomian gland dysfunction.

Authors:  Yana Fu; Huan Xiang; Renjian Hu; Xiaodan Huang; Lin Lin; XiuMing Jin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-24       Impact factor: 3.117

3.  Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double-blind, Randomized, Split-face Study.

Authors:  Hyuck Hoon Kwon; Steven Hoseong Yang; Joon Lee; Byung Cheol Park; Kui Young Park; Jae Yoon Jung; Youin Bae; Gyeong-Hun Park
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

Review 4.  A systematic review of treatments for acne scarring. Part 2: Energy-based techniques.

Authors:  Georgios Kravvas; Firas Al-Niaimi
Journal:  Scars Burn Heal       Date:  2018-08-16

5.  Efficacy and safety comparison between 1927 nm thulium laser and 2940 nm Er:YAG laser in the treatment of facial atrophic acne scarring: a prospective, simultaneous spilt-face clinical trial.

Authors:  Kune Lu; Suiqing Cai
Journal:  Lasers Med Sci       Date:  2021-11-26       Impact factor: 3.161

6.  Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial.

Authors:  T P Afra; Muhammed Razmi T; Tarun Narang; Sunil Dogra; Ashok Kumar
Journal:  JAMA Facial Plast Surg       Date:  2019-03-01       Impact factor: 4.611

7.  Treatment of acne scarring with a novel fractionated, dual-wavelength, picosecond-domain laser incorporating a novel holographic beam-splitter.

Authors:  Eric F Bernstein; Kevin T Schomacker; Lisa D Basilavecchio; Jessica M Plugis; Jayant D Bhawalkar
Journal:  Lasers Surg Med       Date:  2017-09-28       Impact factor: 4.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.